CenterWatch

Lymphoma, B-Cell Clinical Trials

A listing of Lymphoma, B-Cell medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter By:

 

Alabama

Birmingham Alabama

A clinical trial seeking patients for a research study for the treatment of Relapsed/Refractory Aggressive B-cell Lymphomas

Birmingham Alabama 35233

A Phase 1 clinical study for patients with Lymphoma, B-Cell, Non-Hodgkin's Lymphoma

Birmingham Alabama 35249

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Birmingham Alabama 35061

Patients are needed to participate in a clinical research study to evaluate Diffuse Large B-Cell Lymphoma (DLBCL)

Arizona

UPDATED

Tucson Arizona

A Phase 3 clinical study for patients with Lymphoma

Chandler Arizona 85224

A Phase 2 clinical study for patients with Lymphoma, Non-Hodgkin

Gilbert Arizona

A clinical trial to evaluate treatments using Ibrutinib, Lenalidomide and Rituximab for patients with Relapsed Diffuse Large B-Cell Lymphoma or Refractory Diffuse Large B-Cell Lymphoma

Phoenix Arizona 85016

A clinical research study for the treatment of Lymphoma, B-cell or Lymphoma, Large B-cell, Diffuse

Scottsdale Arizona 85259-5499

A clinical trial seeking patients for a research study of CB-839 for the treatment of Hematological Tumors

View More ▼

Scottsdale Arizona 85259

A Phase 2 clinical study for patients with Lymphoma. Non-Hodgkin

Tucson Arizona 85715

A clinical research study of Pixantrone + Rituximab and Gemcitabine + Rituximab for the treatment of Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma or Follicular Grade 3 Lymphoma

Tucson Arizona 85745

A clinical research study of Pixantrone + Rituximab and Gemcitabine + Rituximab for the treatment of Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma or Follicular Grade 3 Lymphoma

Tucson Arizona 85710

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Tucson Arizona 85715

Patients are needed to participate in a clinical research study of Ofatumumab and Bendamustine infusions (Arm A) and Bendamustine infusion (Arm B) to evaluate Lymphoma, Follicular

Arkansas

Bentonville Arkansas 72712

A clinical research study of Pixantrone + Rituximab and Gemcitabine + Rituximab for the treatment of Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma or Follicular Grade 3 Lymphoma

Fayetteville Arkansas 72703

A clinical research study of Pixantrone + Rituximab and Gemcitabine + Rituximab for the treatment of Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma or Follicular Grade 3 Lymphoma

California

UPDATED

Duarte California 91010

A Phase 1-2 Multi-Center Study Evaluating KTE-C19 in Subjects With Refractory Aggressive Non-Hodgkin Lymphoma (NHL)

UPDATED

Greenbrae California

A Phase 3 clinical study for patients with Lymphoma

UPDATED

La Jolla California

A Phase 3 clinical study for patients with Lymphoma

UPDATED

Los Angeles California

A Phase 3 clinical study for patients with Lymphoma

UPDATED

Salinas California

A Phase 3 clinical study for patients with Lymphoma

View More ▼

UPDATED

Stanford California

A Phase 3 clinical study for patients with Lymphoma

Burbank California 91501

Patients are needed to participate in a clinical research study to evaluate Diffuse Large B-Cell Lymphoma (DLBCL)

Duarte California 91010-3000

A clinical research study for the treatment of Lymphoma, B-cell or Lymphoma, Large B-cell, Diffuse

Duarte California 91010

A clinical trial seeking patients for a research study for the treatment of B-cell Non-Hodgkin Lymphoma

Duarte California 91010

A clinical trial to evaluate treatments using Ibrutinib, DA-EPOCH-R and Ibrutinib, Lenalidomide, DA-EPOCH-R for patients with Diffuse Large B Cell Lymphoma Relapsed or Diffuse Large B Cell Lymphoma Refractory

Duarte California 91010

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Los Angeles California 90095

A clinical trial to evaluate treatments using Ibrutinib, DA-EPOCH-R and Ibrutinib, Lenalidomide, DA-EPOCH-R for patients with Diffuse Large B Cell Lymphoma Relapsed or Diffuse Large B Cell Lymphoma Refractory

Los Angeles California

A clinical trial to evaluate treatments using Ibrutinib, Lenalidomide and Rituximab for patients with Relapsed Diffuse Large B-Cell Lymphoma or Refractory Diffuse Large B-Cell Lymphoma

Los Angeles California 90095

A Phase 1 clinical study for patients with B-Cell Malignancies

Los Angeles California 90095

A Phase 2 clinical study for patients with Lymphoma. Non-Hodgkin

Los Angeles California

Patients are needed to participate in a clinical research study evaluating ACP-196 for the treatment of Activated B-cell Diffuse Large B-Cell Lymphoma (ABC DLBCL)

Palm Springs California 92262

Patients are needed to participate in a clinical research study to evaluate Diffuse Large B-Cell Lymphoma (DLBCL)

Pasadena California 91105

A clinical trial to evaluate treatments using MPDL3280A and Obinutuzumab for patients with Follicular Lymphoma, Lymphoma, B-Cell

Sacramento California 95816

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

San Diego California 92123

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

San Francisco California 94143

A clinical research study of Ofatumumab, Etoposide and Cytarabine for the treatment of Diffuse Large Cell Lymphoma Relapsed/Refractory

San Francisco California 94143

A Phase 1 clinical study for patients with Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma

San Francisco California 94115

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Stanford California 94305

A clinical research study for the treatment of Lymphoma, B-cell or Lymphoma, Large B-cell, Diffuse

Stanford California 94305

A clinical trial seeking patients for a research study for the treatment of Cancer - Solid Tumors and B-Cell Non-Hodgkin's Lymphoma

Stanford California 94305

A Phase 1 clinical study for patients with B-Cell Malignancies

Stanford California 94305-5151

A Phase 1/Phase 2 clinical study for patients with B-cell Lymphoma

Stanford California 94305

Patients are needed to participate in a clinical research study evaluating CDX-1127

Stanford California 94305

TLR8 Agonist VTX-2337 in Combo With Local Radiation in Low-Grade B-cell Lymphomas

Sylmar California 91342

Patients are needed to participate in a clinical research study to evaluate Diffuse Large B-Cell Lymphoma (DLBCL)

Colorado

Aurora Colorado 80012

A clinical research study for the treatment of Lymphoma, B-cell or Lymphoma, Large B-cell, Diffuse

Aurora Colorado 80045

A clinical research study of Bendamustine, Obinutuzumab, Polatuzumab Vedotin and Rituximab for the treatment of Lymphoma, Lymphoma B-Cell, Non-Hodgkin's or Follicular Lymphoma

Aurora Colorado 80012

A clinical research study of Pixantrone + Rituximab and Gemcitabine + Rituximab for the treatment of Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma or Follicular Grade 3 Lymphoma

Aurora Colorado 80045

A Phase 2 clinical study for patients with Lymphoma, Non-Hodgkin